Patents by Inventor Paul Christopher

Paul Christopher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9034657
    Abstract: A two step lateral flow assay method for identifying IgE antibodies in a sample comprises applying a sample to a sample port of a device, wherein the device is adapted to deliver the sample to a lateral flow matrix having a plurality of IgE antigen species immobilized at respective positions at a first location; allowing the sample to travel along the lateral flow matrix through the immobilized plurality of IgE antigen species to a second location downstream of the first location; and, after a predetermined period of time, applying liquid buffer to the lateral flow matrix to mobilize labeled reagent which is adapted to bind anti-IgE antibody and which is dried on the lateral flow matrix at a location upstream of the sample port delivery of the sample to the lateral flow matrix, and allowing labeled reagent mobilized by the liquid buffer to travel along the lateral flow matrix through the immobilized plurality of IgE antigen species and bind with any IgE antibody bound to the immobilized IgE antigen species, a
    Type: Grant
    Filed: December 8, 2010
    Date of Patent: May 19, 2015
    Assignee: Phadia AB
    Inventors: Gerd Rundström, Per Matsson, Paul Christopher
  • Publication number: 20110076691
    Abstract: A two step lateral flow assay method for identifying IgE antibodies in a sample comprises applying a sample to a sample port of a device, wherein the device is adapted to deliver the sample to a lateral flow matrix having a plurality of IgE antigen species immobilized at respective positions at a first location; allowing the sample to travel along the lateral flow matrix through the immobilized plurality of IgE antigen species to a second location downstream of the first location; and, after a predetermined period of time, applying liquid buffer to the lateral flow matrix to mobilize labeled reagent which is adapted to bind anti-IgE antibody and which is dried on the lateral flow matrix at a location upstream of the sample port delivery of the sample to the lateral flow matrix, and allowing labeled reagent mobilized by the liquid buffer to travel along the lateral flow matrix through the immobilized plurality of IgE antigen species and bind with any IgE antibody bound to the immobilized IgE antigen species, a
    Type: Application
    Filed: December 8, 2010
    Publication date: March 31, 2011
    Inventors: Gerd Rundström, Per Matsson, Paul Christopher
  • Patent number: 7871781
    Abstract: Lateral flow assay devices and methods for detecting an analyte in a sample which comprises a plurality of nonspecific binding pair members are adapted for two step determinations.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: January 18, 2011
    Assignee: Phadia AB
    Inventors: Gerd Rundström, Per Matsson, Paul Christopher
  • Patent number: 7439079
    Abstract: A lateral flow assay device for detecting the presence or quantity of an analyte within a test sample is provided. The device utilizes multiple zones, one of which serves as an indicator of whether or not the analyte in the test sample is within the “hook effect” region. Based on this indication, a technique may be selected for correlating a measured signal intensity to an analyte concentration or range of concentrations. For example, when it is determined that the test sample falls outside the “hook effect” region, the analyte concentration may be determined using one portion of a dose response curve. On the other hand, when it is determined that the test sample falls within the “hook effect” concentration, the analyte concentration may be determined using another portion of the dose response curve. Alternatively, the sample may simply be diluted for re-performing the assay.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: October 21, 2008
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Xuedong Song, Paul Christopher
  • Publication number: 20070020768
    Abstract: Lateral flow assay devices and methods for detecting a first member of a specific binding pair in a sample which comprises a plurality of nonspecific binding pair members are adapted for two step determinations.
    Type: Application
    Filed: May 23, 2006
    Publication date: January 25, 2007
    Inventors: Gerd Rundstrom, Per Matsson, Paul Christopher
  • Publication number: 20060246601
    Abstract: A lateral flow assay device for detecting the presence or quantity of an analyte within a test sample is provided. The device utilizes multiple zones, one of which serves as an indicator of whether or not the analyte in the test sample is within the “hook effect” region. Based on this indication, a technique may be selected for correlating a measured signal intensity to an analyte concentration or range of concentrations. For example, when it is determined that the test sample falls outside the “hook effect” region, the analyte concentration may be determined using one portion of a dose response curve. On the other hand, when it is determined that the test sample falls within the “hook effect” concentration, the analyte concentration may be determined using another portion of the dose response curve. Alternatively, the sample may simply be diluted for re-performing the assay.
    Type: Application
    Filed: April 29, 2005
    Publication date: November 2, 2006
    Inventors: Xuedong Song, Paul Christopher
  • Publication number: 20060127886
    Abstract: There is provided a lateral flow assay device for detecting the presence or quantity of an analyte residing in a test sample where the lateral flow assay device has a porous membrane in communication with a conjugate pad and a wicking pad. The porous membrane has a detection zone which has an immobilized first capture reagent configured to bind to at least a portion of the analyte and analyte-conjugate complexes to generate a detection signal. A control zone may be located downstream from the detection zone on the porous membrane and has a second capture reagent immobilized within the control zone. The conjugate pad is located upstream from the detection zone, and has detection probes with specific binding members for the analyte. The sample is deposited between the control and detection zones. A buffer release zone is located upstream of the conjugate pad and provides for buffer addition to the device, the buffer serving to move the detection probes to the detection and control zones.
    Type: Application
    Filed: December 15, 2004
    Publication date: June 15, 2006
    Inventors: Rosann Kaylor, Ning Wei, Chibueze Chidebelu-Eze, Shawn Feaster, Paul Christopher
  • Publication number: 20050090198
    Abstract: The inventor shows new, lower atmospheric attenuation in the 75-98 GHz satellite band. This lower attenuation occurs at 90% link availability. This opens up the 75-98 GHz satellite band immediately for users who can accept 90% link availability. The inventor then uses cloud autocorrelation functions to show compact switched arrays of ground sites to support availability requirements greater than 97%. This method applies to the new 75-98 GHz satellite band and the 3 micron-10 micron laser bands. These compact arrays would allow conventional availability to be attained in these previously unreliable and unattainable bands, at important temperate zone sites as New York City and Rome. The inventor shows compact square arrays with length of a side as typically less than 20 km, and discusses equilateral triangular arrays with similar lengths. Dual sites are shown to usually require larger separation distances.
    Type: Application
    Filed: October 14, 2004
    Publication date: April 28, 2005
    Inventor: Paul Christopher